Literature DB >> 10699925

CD44s expression in human colon carcinomas influences growth of liver metastases.

S H Choi1, K Takahashi, H Eto, S S Yoon, K K Tanabe.   

Abstract

CD44 is a family of cell-surface adhesion molecules which exist in several isoforms arising from mRNA alternative. Malignant transformation of colonic mucosa is associated with alterations in CD44 expression, which result in up-regulation of high-molecular-weight CD44 isoforms and down-regulation of CD44s. We have demonstrated that stable transfection of CD44s into colon-carcinoma cell lines reduces their tumorigenicity. To understand the influence of CD44s expression on the metastatic potential of human colon carcinomas, we measured the ability of several different CD44s-transfected colon carcinomas to establish experimental liver metastases following splenic inoculation in mice. We observed that introduction of CD44s into 2 different human colon carcinoma cell lines, HT29 and KM12C6, resulted in reduced growth of liver metastases by as much as 75%. To explore the relationship between hyaluronate adhesion and metastasis, we transfected HT29 cells with cDNA encoding a mutant CD44s that does not bind to hyaluronate. HT29 transfectants expressing this mutant CD44s demonstrate an 84% reduction in growth of liver metastases, despite minimal binding to hyaluronate by the mutant CD44s. In concert, these results indicate that CD44s down-regulation, which occurs with malignant transformation of colonic mucosa, is associated with enhanced growth of experimental liver metastases. Consequently, the functional consequences of CD44s down-regulation in colon carcinomas may be just as significant as the consequences of up-regulation of other CD44 isoforms. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699925     DOI: 10.1002/(sici)1097-0215(20000215)85:4<523::aid-ijc13>3.0.co;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

2.  Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.

Authors:  Matthew R Dallas; Guosheng Liu; Wei-Chiang Chen; Susan N Thomas; Denis Wirtz; David L Huso; Konstantinos Konstantopoulos
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

3.  Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

4.  In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.

Authors:  Allal Ouhtit; Zakaria Y Abd Elmageed; Mohamed E Abdraboh; Tong F Lioe; Madhwa H G Raj
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

Review 5.  Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?

Authors:  F Gieseler; P Rudolph; G Kloeppel; U R Foelsch
Journal:  Int J Colorectal Dis       Date:  2003-05-28       Impact factor: 2.571

6.  Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.

Authors:  Diego M Marzese; Michelle Liu; Jamie L Huynh; Hajime Hirose; Nicholas C Donovan; Kelly T Huynh; Eiji Kiyohara; Kelly Chong; David Cheng; Ryo Tanaka; Jinhua Wang; Donald L Morton; Garni Barkhoudarian; Daniel F Kelly; Dave S B Hoon
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-30       Impact factor: 4.693

7.  Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.

Authors:  Nhi Huynh; Arthur Shulkes; Graham Baldwin; Hong He
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

8.  Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.

Authors:  B Desai; T Ma; J Zhu; M A Chellaiah
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

9.  Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.

Authors:  Suniti Misra; Vincent C Hascall; Carla De Giovanni; Roger R Markwald; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

10.  The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.

Authors:  Anita Yakkundi; Lynn McCallum; Anthony O'Kane; Hayder Dyer; Jenny Worthington; Hayley D McKeen; Lana McClements; Christopher Elliott; Helen O McCarthy; David G Hirst; Tracy Robson
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.